Evaluates multifunctional biomedical properties of biogenic TiO2-Zn nanocomposites, indicating potential for multitarget therapy.
Biogenic TiO 2 –Zn nanocomposites from Red Sea Bacillus tequilensis MYG163 form an anatase–wurtzite heterojunction (8–15 nm) with antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and hemocompatibility activities for multitarget therapy.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: